AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 28398968 — intervention group
Group type: COMPARATOR
Intervention: treadmill
Number of subjects: 18
Study 28398968 — intervention group
Group type: COMPARATOR
Intervention: StDCS+treadmill
Number of subjects: 18
Study 25736045 — intervention group
Group type: EXPERIMENTAL
Intervention: Ferric Citrate (FC)
Number of subjects: 441
Study 25163906 — intervention group
Group type: EXPERIMENTAL
Intervention: Cilengitide 2000 mg intravenously twice weekly combined with temozolomide chemoradiotherapy
Number of subjects: 545
Study 25163906 — intervention group
Group type: COMPARATOR
Intervention: Temozolomide chemoradiotherapy alone
Number of subjects: 545
Study 25163906 — intervention group
Group type: EXPERIMENTAL
Intervention: Cilengitide
Number of subjects: 545
Study 22890251 — intervention group
Group type: EXPERIMENTAL
Intervention: Multifaceted intervention involving evidence-based practices and the Comprehensive Unit-based Safety Program
Number of subjects: 45
Study 22890251 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 45
Study 19648823 — intervention group
Group type: EXPERIMENTAL
Intervention: Raltegravir (400 mg twice a day after 48 weeks)
Number of subjects: 198
Study 19648823 — intervention group
Group type: COMPARATOR
Intervention: Efavirenz (600 mg every day)
Number of subjects: 198
Study 19648823 — intervention group
Group type: EXPERIMENTAL
Intervention: Raltegravir
Number of subjects: 198
Study 19648823 — intervention group
Group type: COMPARATOR
Intervention: Efavirenz
Number of subjects: 198
Study 17452676 — intervention group
Group type: EXPERIMENTAL
Intervention: Letrozole
Number of subjects: 4445
Study 17452676 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4445
Study 16987587 — intervention group
Group type: EXPERIMENTAL
Intervention: Group 3 (specific training method not detailed)
Number of subjects: 61
Study 16987587 — intervention group
Group type: COMPARATOR
Intervention: All groups (including Group 1 and Group 2)
Number of subjects: 61
Study 16987587 — intervention group
Group type: COMPARATOR
Intervention: Whole body manikins
Number of subjects: 61
Study 14626331 — intervention group
Group type: EXPERIMENTAL
Intervention: Electronic Data Capture (EDC) version of the Asthma Quality of Life Questionnaire (AQLQ(S))
Number of subjects: 154
Study 14626331 — intervention group
Group type: EXPERIMENTAL
Intervention: Electronic Data Capture (EDC) version of the Pediatric Asthma Quality of Life Questionnaire (PAQLQ(S))
Number of subjects: 154
Study 14626331 — intervention group
Group type: EXPERIMENTAL
Intervention: Electronic Data Capture (EDC) version of the Pediatric Asthma Caregiver's Quality of Life Questionnaire (PACQLQ)
Number of subjects: 154
Study 14626331 — intervention group
Group type: EXPERIMENTAL
Intervention: Preference for electronic version
Number of subjects: 154
Study 10868771 — intervention group
Group type: EXPERIMENTAL
Intervention: Support intervention with visits from a 'similar other' (trained veterans) during hospital stay
Number of subjects: 190
Study 10868771 — intervention group
Group type: COMPARATOR
Intervention: Usual hospital care
Number of subjects: 190
Study 8800392 — intervention group
Group type: EXPERIMENTAL
Intervention: Naltrexone (NTX), 50 mg/day, po
Number of subjects: 16
Study 8800392 — intervention group
Group type: COMPARATOR
Intervention: Inactive placebo
Number of subjects: 16
Study 1731285 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal E2 0.1 mg for 24.5 days of each 28‐day cycle for 96 weeks
Number of subjects: 60
Study 1731285 — intervention group
Group type: COMPARATOR
Intervention: Transdermal E2 0.1 mg plus 10 mg of medroxyprogesterone acetate from days 13‐25 of each cycle
Number of subjects: 60
Study 6419578 — intervention group
Group type: EXPERIMENTAL
Intervention: bepridil
Number of subjects: 20
Study 6419578 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 20
Study 31003690 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical sesame oil with massage (10 drops, twice a day for 7 days)
Number of subjects: 60
Study 31003690 — intervention group
Group type: COMPARATOR
Intervention: Massage only (control group)
Number of subjects: 60
Study 26544173 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse-led structured discharge planning program
Number of subjects: 143
Study 26544173 — intervention group
Group type: COMPARATOR
Intervention: Standard routine care
Number of subjects: 143
Study 24988438 — intervention group
Group type: EXPERIMENTAL
Intervention: RAL 800 mg by chewing
Number of subjects: 12
Study 24988438 — intervention group
Group type: COMPARATOR
Intervention: RAL 400 mg by swallowing
Number of subjects: 12
Study 23700028 — intervention group
Group type: EXPERIMENTAL
Intervention: Consent documents with high processability, eighth-grade reading level, and graphics
Number of subjects: 640
Study 23700028 — intervention group
Group type: COMPARATOR
Intervention: Consent documents without high processability, eighth-grade reading level, and graphics
Number of subjects: 640
Study 20817535 — intervention group
Group type: EXPERIMENTAL
Intervention: Laserlight visual cue
Number of subjects: 26
Study 19865065 — intervention group
Group type: EXPERIMENTAL
Intervention: Coenzyme Q10 terclatrate (QTer) 200 mg orally once daily for 7 days before noise exposure
Number of subjects: 20
Study 19865065 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 19865065 — intervention group
Group type: EXPERIMENTAL
Intervention: Coenzyme Q10 terclatrate (QTer)
Number of subjects: 20
Study 17846807 — intervention group
Group type: EXPERIMENTAL
Intervention: Finger cover made of soft, thin polyester non‐woven fabric
Number of subjects: 12
Study 17846807 — intervention group
Group type: COMPARATOR
Intervention: No finger cover (control)
Number of subjects: 12
Study 15613828 — intervention group
Group type: EXPERIMENTAL
Intervention: Hand massage
Number of subjects: 47
Study 15613828 — intervention group
Group type: EXPERIMENTAL
Intervention: Hand holding
Number of subjects: 47
Study 15613828 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 47
Study 11691521 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous transluminal coronary angioplasty (PTCA)
Number of subjects: 1829
Study 11691521 — intervention group
Group type: COMPARATOR
Intervention: Coronary artery bypass graft (CABG)
Number of subjects: 1829
Study 11691521 — intervention group
Group type: EXPERIMENTAL
Intervention: PTCA
Number of subjects: 1829
Study 11691521 — intervention group
Group type: COMPARATOR
Intervention: CABG
Number of subjects: 1829
Study 9158165 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine (transdermal, given for 5 days)
Number of subjects: 14
Study 8086609 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 3436102 — intervention group
Group type: EXPERIMENTAL
Intervention: 80 mmol/day KCl (Slow‐K, Ciba Geigy)
Number of subjects: 44
Study 3436102 — intervention group
Group type: COMPARATOR
Intervention: Matching placebo
Number of subjects: 44
Study 27010325 — intervention group
Group type: EXPERIMENTAL
Intervention: Observational method
Number of subjects: 451
Study 27010325 — intervention group
Group type: COMPARATOR
Intervention: Incident reports
Number of subjects: 451
Study 27010325 — intervention group
Group type: COMPARATOR
Intervention: Global Trigger Tool method
Number of subjects: 451
Study 27010325 — intervention group
Group type: EXPERIMENTAL
Intervention: Observational data
Number of subjects: 451
Study 31161227 — intervention group
Group type: EXPERIMENTAL
Intervention: Orthodontic space closure initiated after 2-4 weeks (group A, n=41)
Number of subjects: 25
Study 31161227 — intervention group
Group type: COMPARATOR
Intervention: Orthodontic space closure initiated ≥ 12 weeks after tooth extraction (group B, n=25)
Number of subjects: 25
Study 28341782 — intervention group
Group type: EXPERIMENTAL
Intervention: GDF-15
Number of subjects: 861
Study 28341782 — intervention group
Group type: EXPERIMENTAL
Intervention: NTproBNP
Number of subjects: 861
Study 28341782 — intervention group
Group type: EXPERIMENTAL
Intervention: hs-TnT
Number of subjects: 861
Study 28341782 — intervention group
Group type: COMPARATOR
Intervention: NTproBNP and hs-TnT
Number of subjects: 861
Study 25906565 — intervention group
Group type: EXPERIMENTAL
Intervention: Triple-strong stimulation therapy group
Number of subjects: 120
Study 25906565 — intervention group
Group type: COMPARATOR
Intervention: Acupoint plaster therapy group
Number of subjects: 120
Study 24374951 — intervention group
Group type: EXPERIMENTAL
Intervention: PCR technique (broad-range 16S rDNA detection, runtime 6 h)
Number of subjects: 50
Study 24374951 — intervention group
Group type: COMPARATOR
Intervention: Blood culture (monitored for 6 days)
Number of subjects: 50
Study 24374951 — intervention group
Group type: EXPERIMENTAL
Intervention: PCR technique
Number of subjects: 50
Study 22012043 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative inspiratory muscle training
Number of subjects: 32
Study 22012043 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 32
Study 19784467 — intervention group
Group type: EXPERIMENTAL
Intervention: InGaAlP laser (660 nm) and GaAlAs laser (780 nm), 25 mW potency, 6.3J/cm(2) dose, 10‐s irradiation time, followed by conventional treatment (Mucositis Formula)
Number of subjects: 22
Study 19784467 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment (Mucositis Formula) only
Number of subjects: 22
Study 16825002 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcification group (moderate or heavily calcified aortic valve)
Number of subjects: 55
Study 16825002 — intervention group
Group type: COMPARATOR
Intervention: Noncalcification group (no or mildly calcified aortic valve)
Number of subjects: 55
Study 15116086 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified dairy butter fat (reduced saturated:unsaturated fatty acid ratio)
Number of subjects: 18
Study 15116086 — intervention group
Group type: COMPARATOR
Intervention: Conventional high saturated butter fat
Number of subjects: 18
Study 15116086 — intervention group
Group type: EXPERIMENTAL
Intervention: Both dietary treatments
Number of subjects: 18
Study 14649615 — intervention group
Group type: COMPARATOR
Intervention: 4-minute, 1.23% APF gel treatment
Number of subjects: 12
Study 14649615 — intervention group
Group type: EXPERIMENTAL
Intervention: AL irradiation of 11.5 J/cm2 (0.23 1‐W, 5‐mm beam size, 10 seconds)
Number of subjects: 12
Study 14649615 — intervention group
Group type: EXPERIMENTAL
Intervention: AL irradiation followed by APF gel treatment
Number of subjects: 12
Study 14649615 — intervention group
Group type: COMPARATOR
Intervention: No treatment (control)
Number of subjects: 12
Study 10993625 — intervention group
Group type: EXPERIMENTAL
Intervention: Early laparoscopic cholecystectomy (LC)
Number of subjects: 43
Study 10993625 — intervention group
Group type: COMPARATOR
Intervention: Delayed laparoscopic cholecystectomy (LC)
Number of subjects: 43
Study 8843757 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 8843757 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrocortisone
Number of subjects: 15
Study 8843757 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone
Number of subjects: 15
Study 1512910 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous passive motion (CPM) plus standardized rehabilitation
Number of subjects: 102
Study 1512910 — intervention group
Group type: COMPARATOR
Intervention: Standardized rehabilitation alone
Number of subjects: 102
Study 6700643 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone (4 mg every 6 hours for 48 hours)
Number of subjects: 8
Study 6700643 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study 31376858 — intervention group
Group type: EXPERIMENTAL
Intervention: Saturated fat tax (mean absolute difference 1.77%)
Number of subjects: 1132
Study 31376858 — intervention group
Group type: EXPERIMENTAL
Intervention: Sugar tax (mean absolute difference 1.09%)
Number of subjects: 1132
Study 31376858 — intervention group
Group type: EXPERIMENTAL
Intervention: Salt tax (mean absolute difference 1.31%)
Number of subjects: 1132
Study 31376858 — intervention group
Group type: COMPARATOR
Intervention: Control (no change in prices)
Number of subjects: 1132
Study 31376858 — intervention group
Group type: EXPERIMENTAL
Intervention: Sweetened beverage tax (0.18% increase)
Number of subjects: 1132
Study 31376858 — intervention group
Group type: EXPERIMENTAL
Intervention: Fruit and vegetable subsidy (0.41% increase)
Number of subjects: 1132
Study 30327362 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin Pump
Number of subjects: 248
Study 30327362 — intervention group
Group type: COMPARATOR
Intervention: Multiple Daily Injections (MDI)
Number of subjects: 248
Study 26205890 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise + placebo (D‐Ex+)
Number of subjects: 409
Study 26205890 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise + vitamin D 800 IU/day (D+Ex+)
Number of subjects: 409
Study 26205890 — intervention group
Group type: COMPARATOR
Intervention: No exercise + placebo (D‐Ex‐)
Number of subjects: 409
Study 26205890 — intervention group
Group type: COMPARATOR
Intervention: No exercise + vitamin D 800 IU/day (D+Ex‐)
Number of subjects: 409
Study 26205890 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise intervention
Number of subjects: 409
Study 26205890 — intervention group
Group type: EXPERIMENTAL
Intervention: D‐Ex+
Number of subjects: 409
Study 26205890 — intervention group
Group type: EXPERIMENTAL
Intervention: D+Ex+
Number of subjects: 409
Study 26205890 — intervention group
Group type: EXPERIMENTAL
Intervention: D‐Ex‐
Number of subjects: 409
Study 25188224 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser peripheral iridotomy (LPI)
Number of subjects: 72
Study 25188224 — intervention group
Group type: COMPARATOR
Intervention: Untreated eyes (control group)
Number of subjects: 72
Study 25188224 — intervention group
Group type: COMPARATOR
Intervention: Low-risk untreated eyes
Number of subjects: 72
Study 25188224 — intervention group
Group type: EXPERIMENTAL
Intervention: High-risk treated eyes (LPI)
Number of subjects: 72
Study 25188224 — intervention group
Group type: COMPARATOR
Intervention: High-risk untreated eyes
Number of subjects: 72
Study 25188224 — intervention group
Group type: COMPARATOR
Intervention: Low-risk eyes
Number of subjects: 72
Study 22000577 — intervention group
Group type: COMPARATOR
Intervention: Core decompression
Number of subjects: 40
Study 22000577 — intervention group
Group type: EXPERIMENTAL
Intervention: Autologous bone marrow mononuclear cell instillation after core decompression
Number of subjects: 40
Study 20335871 — intervention group
Group type: EXPERIMENTAL
Intervention: Afroze incision
Number of subjects: 1200
Study 20335871 — intervention group
Group type: COMPARATOR
Intervention: Millard incision
Number of subjects: 1200
Study 20335871 — intervention group
Group type: COMPARATOR
Intervention: Pfeifer incision
Number of subjects: 1200
Study 20335871 — intervention group
Group type: EXPERIMENTAL
Intervention: All three incisions
Number of subjects: 1200
Study 17875558 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole body vibration (20 Hz, 5 mm amplitude, 1 minute, 6 times in one session)
Number of subjects: 16
Study 17875558 — intervention group
Group type: COMPARATOR
Intervention: Control group (no vibration, same standing protocol)
Number of subjects: 16
Study 16178493 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnetic insoles
Number of subjects: 83
Study 16178493 — intervention group
Group type: COMPARATOR
Intervention: Sham-magnetic insoles
Number of subjects: 83
Study 12047427 — intervention group
Group type: EXPERIMENTAL
Intervention: Body mass index greater than 30
Number of subjects: 15454
Study 12047427 — intervention group
Group type: COMPARATOR
Intervention: Body mass index of 20-24.99
Number of subjects: 15454
Study 12047427 — intervention group
Group type: EXPERIMENTAL
Intervention: Body mass index
Number of subjects: 15454
Study 10572341 — intervention group
Group type: EXPERIMENTAL
Intervention: Milnacipran (SNRI)
Number of subjects: 0
Study 10572341 — intervention group
Group type: COMPARATOR
Intervention: TCA
Number of subjects: 0
Study 10572341 — intervention group
Group type: COMPARATOR
Intervention: SSRI
Number of subjects: 0
Study 7787850 — intervention group
Group type: EXPERIMENTAL
Intervention: Harness-supported treadmill ambulation with 40% body weight supported
Number of subjects: 2
Study 7787850 — intervention group
Group type: EXPERIMENTAL
Intervention: Harness-supported treadmill ambulation with full body weight and 20% body weight supported
Number of subjects: 2
Study 7787850 — intervention group
Group type: EXPERIMENTAL
Intervention: Harness-supported treadmill ambulation at 1.34 m/sec (3.0 mph)
Number of subjects: 2
Study 2336873 — intervention group
Group type: EXPERIMENTAL
Intervention: Immunotherapy with a vaccine consisting of autoclaved Mycobacterium w
Number of subjects: 54
Study 2336873 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy and placebo injections
Number of subjects: 54
Study 377219 — intervention group
Group type: EXPERIMENTAL
Intervention: Weekly immunotherapy combining BCG and irradiated leukaemic cells
Number of subjects: 31
Study 377219 — intervention group
Group type: COMPARATOR
Intervention: Monthly reinduction chemotherapy
Number of subjects: 31
Study 30160559 — intervention group
Group type: EXPERIMENTAL
Intervention: Morning exercise (09:00 h)
Number of subjects: 12
Study 30160559 — intervention group
Group type: EXPERIMENTAL
Intervention: Afternoon exercise (16:00 h)
Number of subjects: 12
Study 30160559 — intervention group
Group type: COMPARATOR
Intervention: No exercise (CON)
Number of subjects: 12
Study 28086871 — intervention group
Group type: EXPERIMENTAL
Intervention: iCaPPS- Rehab© for rehabilitation of stroke patients at community level
Number of subjects: 0
Study 28086871 — intervention group
Group type: EXPERIMENTAL
Intervention: iCaPPS- Swallow© for screening and managing stroke related swallowing problems
Number of subjects: 0
Study 25744500 — intervention group
Group type: EXPERIMENTAL
Intervention: Accelerated high-frequency (HF) rTMS treatment
Number of subjects: 15
Study 25744500 — intervention group
Group type: COMPARATOR
Intervention: Sham control
Number of subjects: 15
Study 25158369 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic visual presentation method (soundless animated video presentation)
Number of subjects: 20
Study 25158369 — intervention group
Group type: COMPARATOR
Intervention: Static visual presentation method (wordless picture book)
Number of subjects: 20
Study 20536910 — intervention group
Group type: EXPERIMENTAL
Intervention: Maximal oxygen consumption (VO(2max)) measured during a maximal exercise stress test on a bicycle ergometer with a linear workload increase of 20 W/min.
Number of subjects: 1349
Study 20536910 — intervention group
Group type: EXPERIMENTAL
Intervention: Maximal metabolic equivalents (METs) and maximal workload measured during the same exercise test.
Number of subjects: 1349
Study 20536910 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic diseases (0, 1, 2 or ≥3) as a variable affecting VO(2max).
Number of subjects: 1349
Study 19447570 — intervention group
Group type: COMPARATOR
Intervention: Sustained-release (SR) bupropion plus transdermal nicotine patch
Number of subjects: 58
Study 19447570 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 58
Study 16512758 — intervention group
Group type: EXPERIMENTAL
Intervention: SRP plus chlorhexidine chip
Number of subjects: 34
Study 16512758 — intervention group
Group type: COMPARATOR
Intervention: SRP alone
Number of subjects: 34
Study 12725547 — intervention group
Group type: EXPERIMENTAL
Intervention: Skin-to-skin group
Number of subjects: 176
Study 12725547 — intervention group
Group type: EXPERIMENTAL
Intervention: Mother's arms group
Number of subjects: 176
Study 12725547 — intervention group
Group type: COMPARATOR
Intervention: Nursery group
Number of subjects: 176
Study 11545470 — intervention group
Group type: EXPERIMENTAL
Intervention: Pantomiming tool‐use gestures with either the left hand or right hand
Number of subjects: 10
Study 11545470 — intervention group
Group type: COMPARATOR
Intervention: Repetitive, oppositional movements between thumb and index finger (Control)
Number of subjects: 10
Study 11545470 — intervention group
Group type: EXPERIMENTAL
Intervention: Right-hand praxis
Number of subjects: 10
Study 11545470 — intervention group
Group type: EXPERIMENTAL
Intervention: Left-hand praxis
Number of subjects: 10
Study 9270638 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative chemotherapy (cisplatin and 5-fluorouracil)
Number of subjects: 147
Study 9270638 — intervention group
Group type: COMPARATOR
Intervention: Surgical therapy alone
Number of subjects: 147
Study 7876487 — intervention group
Group type: EXPERIMENTAL
Intervention: Double incision open technique
Number of subjects: 30
Study 7876487 — intervention group
Group type: COMPARATOR
Intervention: Standard incision technique
Number of subjects: 30
Study 3060625 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefmetazole (CMZ)
Number of subjects: 403
Study 3060625 — intervention group
Group type: COMPARATOR
Intervention: Cephalothin (C)
Number of subjects: 403
Study 1346414 — intervention group
Group type: EXPERIMENTAL
Intervention: Dermatan sulphate
Number of subjects: 0
Study 332472 — intervention group
Group type: EXPERIMENTAL
Intervention: Imipramine pamoate
Number of subjects: 57
Study 332472 — intervention group
Group type: COMPARATOR
Intervention: Amitriptyline
Number of subjects: 57
Study 30475752 — intervention group
Group type: EXPERIMENTAL
Intervention: 6-month trunk prevention training program
Number of subjects: 103
Study 30475752 — intervention group
Group type: COMPARATOR
Intervention: Control group (not performing trunk prevention training)
Number of subjects: 103
Study 27852098 — intervention group
Group type: EXPERIMENTAL
Intervention: Water plus 100 mg simethicone (group B)
Number of subjects: 297
Study 27852098 — intervention group
Group type: EXPERIMENTAL
Intervention: Water plus 100 mg simethicone plus 600 mg N-acetylcysteine (group C)
Number of subjects: 297
Study 27852098 — intervention group
Group type: COMPARATOR
Intervention: Water (placebo, group A)
Number of subjects: 297
Study 25912524 — intervention group
Group type: EXPERIMENTAL
Intervention: Kangaroo Mother Care (n=38)
Number of subjects: 80
Study 25912524 — intervention group
Group type: COMPARATOR
Intervention: Incubator group (n=37)
Number of subjects: 80
Study 24018711 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamsulosin (0.4 mg o.d.) and ketoconazole (200 mg t.d.s.)
Number of subjects: 106
Study 24018711 — intervention group
Group type: COMPARATOR
Intervention: Tamsulosin (0.4 mg o.d.) and placebo
Number of subjects: 106
Study 21233029 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide 64 μg/dose nasal spray
Number of subjects: 48
Study 21233029 — intervention group
Group type: COMPARATOR
Intervention: Budecort Aqua® 64 μg/dose nasal spray
Number of subjects: 48
Study 18653484 — intervention group
Group type: EXPERIMENTAL
Intervention: Licofelone (200 mg twice a day)
Number of subjects: 355